Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Invasive pulmonary aspergillosis.

Ilana Oren1, Noam Goldstein

  • 1Infectious Diseases Unit, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. i_oren@ramban.health.gov.il

Current Opinion in Pulmonary Medicine
|May 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Transplantation and cellular therapy·2024
Same author

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.

The Journal of antimicrobial chemotherapy·2023
Same author

Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2022
Same author

Immune reconstitution inflammatory syndrome (IRIS) in a patient with neuro pulmonary nocardiosis following hematopoietic cells transplantation (HCT).

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2021
Same author

Invasive Pulmonary Aspergillosis in Multiple Myeloma patients: A sizeable diagnosis in the era of novel anti-myeloma therapies.

Mycoses·2021
Same author

Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.

Mycopathologia·2020

Invasive pulmonary aspergillosis, a severe fungal lung infection in immunocompromised individuals, has poor survival rates due to diagnostic and treatment challenges. Advances in imaging and non-culture diagnostics, alongside new antifungal drugs, offer hope for improved patient outcomes.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Invasive pulmonary aspergillosis is a frequent fungal infection in immunocompromised patients, particularly stem cell transplant recipients and those with hematological malignancies.
  • Poor survival rates are linked to challenges in early diagnosis and limited effective treatments.
  • Ongoing research aims to enhance diagnostic accuracy and therapeutic strategies.

Purpose of the Study:

  • To review current diagnostic techniques for invasive pulmonary aspergillosis.
  • To discuss emerging antifungal therapies for invasive pulmonary aspergillosis.
  • To highlight the need for improved early detection and treatment protocols.

Main Methods:

  • Review of current literature on diagnostic modalities.

Related Experiment Videos

  • Analysis of emerging antifungal drug development.
  • Synthesis of data on patient outcomes and risk factors.

    • Main Results:

    • High-resolution computed tomography (HRCT) and sequential non-culture-based monitoring (Aspergillus antigen and DNA) improve early diagnosis.
    • New antifungal agents demonstrate enhanced safety, efficacy, and pharmacokinetic profiles.
    • Despite advances, early diagnosis and effective treatment remain critical challenges.

    Conclusions:

    • Early and repeated diagnostic measures, including advanced imaging and molecular methods, are crucial for improving survival.
    • Emerging antifungal drugs offer promising therapeutic options for managing invasive pulmonary aspergillosis.
    • Continued research and clinical vigilance are essential to combat this life-threatening infection.